Atrial Fibrillation Management Guidelines

Initial Treatment and Assessment

The American College of Cardiology recommends initiating rate control with beta-blockers or non-dihydropyridine calcium channel blockers (diltiazem, verapamil) combined with immediate stroke risk assessment and anticoagulation for patients with CHA₂DS₂-VASc score ≥2 1
For hemodynamically unstable patients, the American College of Cardiology suggests performing immediate synchronized electrical cardioversion without waiting for anticoagulation 2, 1

The American College of Cardiology recommends calculating CHA₂DS₂-VASc score immediately to assess stroke risk, with points assigned for congestive heart failure, hypertension, age, diabetes, prior stroke, vascular disease, and sex category 1
For patients with CHA₂DS₂-VASc score ≥2, the American College of Cardiology recommends initiating oral anticoagulation immediately 1
Direct oral anticoagulants (DOACs) are preferred over warfarin except in patients with mechanical heart valves or moderate-to-severe mitral stenosis, according to the American College of Cardiology 1

For patients with LVEF >40%, the American College of Cardiology recommends using beta-blockers or non-dihydropyridine calcium channel blockers as first-line therapy for rate control 1
For patients with LVEF ≤40%, the American College of Cardiology suggests using beta-blockers and/or digoxin for rate control 1

The American College of Cardiology recommends considering rhythm control in patients with hemodynamic instability, symptomatic patients despite adequate rate control, younger patients with new-onset atrial fibrillation, and patients with suspected rate-related cardiomyopathy 1, 2
For patients with AF duration >48 hours or unknown duration, the American College of Cardiology recommends anticoagulating therapeutically for at least 3 weeks before cardioversion and continuing anticoagulation for minimum 4 weeks after cardioversion 2, 1

For patients with Wolff-Parkinson-White syndrome and pre-excited AF, the American College of Cardiology recommends immediate DC cardioversion if hemodynamically unstable, and IV procainamide or ibutilide if stable 1, 2

The American College of Cardiology recommends monitoring anticoagulation therapy, with INR weekly during initiation and monthly when stable for warfarin, and assessing renal function at least annually for DOACs 2, 1
The American College of Cardiology suggests considering catheter ablation as second-line therapy when antiarrhythmic drugs fail to control symptoms 1

The American College of Cardiology recommends addressing modifiable risk factors, such as hypertension, heart failure, diabetes, obesity, obstructive sleep apnea, physical inactivity, and high alcohol intake, to reduce atrial fibrillation episodes 1